Agarwal Arjun sold ORKA
July 13, 2026 · Form 4 insider transaction
Agarwal Arjun sold 5,656 shares of Oruka Therapeutics, Inc. at $84.90 per share, a transaction worth $480.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,656
Price
$84.90
Total value
$480.2K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 13, 2026
Filing dateJuly 13, 2026
Shares owned after15,612
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.54 to $85.50, inclusive.